Cellular origin of glioblastoma and its implication in precision therapy | |
Yao, Maojin2; Li, Shu3; Wu, Xiaojun4; Diao, Shuo2,5; Zhang, Guoxin6; He, Hua1,4; Bian, Liuguan7; Lu, Yicheng4 | |
刊名 | CELLULAR & MOLECULAR IMMUNOLOGY |
2018-08 | |
卷号 | 15期号:8页码:737-739 |
ISSN号 | 1672-7681 |
DOI | 10.1038/cmi.2017.159 |
文献子类 | Editorial Material |
资助项目 | State Key Laboratory of Drug Research[NSFC81302187] ; State Key Laboratory of Drug Research[CWS14C063] ; State Key Laboratory of Drug Research[SIMM1705KF-10] |
WOS关键词 | HIGH-GRADE GLIOMA ; MOSAIC ANALYSIS ; DOUBLE MARKERS ; PHENOTYPE ; SURVIVAL ; REVEALS |
WOS研究方向 | Immunology |
语种 | 英语 |
出版者 | CHIN SOCIETY IMMUNOLOGY |
WOS记录号 | WOS:000448428500004 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.183/handle/2S10ELR8/279630] |
专题 | 新药研究国家重点实验室 中科院受体结构与功能重点实验室 |
通讯作者 | He, Hua; Bian, Liuguan |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Beijing 201203, Peoples R China; 2.Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA; 3.Wannan Med Coll, Dept Pathophysiol, Wuhu 241002, Peoples R China; 4.Second Mil Med Univ, Affiliated Hosp 2, Changzheng Hosp, Dept Neurosurg, 415 Fengyang Rd, Shanghai 200003, Peoples R China; 5.Dalian Med Univ, Affiliated Hosp 1, Dept Neurosurg, Dalian 116044, Peoples R China; 6.Univ Calif San Diego, Brain Tumor Inst, La Jolla, CA 92093 USA; 7.Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Neurosurg, Shanghai 200025, Peoples R China |
推荐引用方式 GB/T 7714 | Yao, Maojin,Li, Shu,Wu, Xiaojun,et al. Cellular origin of glioblastoma and its implication in precision therapy[J]. CELLULAR & MOLECULAR IMMUNOLOGY,2018,15(8):737-739. |
APA | Yao, Maojin.,Li, Shu.,Wu, Xiaojun.,Diao, Shuo.,Zhang, Guoxin.,...&Lu, Yicheng.(2018).Cellular origin of glioblastoma and its implication in precision therapy.CELLULAR & MOLECULAR IMMUNOLOGY,15(8),737-739. |
MLA | Yao, Maojin,et al."Cellular origin of glioblastoma and its implication in precision therapy".CELLULAR & MOLECULAR IMMUNOLOGY 15.8(2018):737-739. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论